$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2014 Q3 Form 10-K Financial Statement

#000156459014005961 Filed on November 25, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 2013 Q3
Revenue $43.75K $175.0K $43.75K
YoY Change 0.0% -39.71% 9.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.160M $19.40M $2.100M
YoY Change 336.19% 139.51% -28.33%
% of Gross Profit
Research & Development $8.420M $23.14M $4.120M
YoY Change 104.37% 165.78% 101.96%
% of Gross Profit
Depreciation & Amortization $200.0K $1.346M $400.0K
YoY Change -50.0% -23.17% 0.0%
% of Gross Profit
Operating Expenses $20.23M $53.45M $8.040M
YoY Change 151.62% 114.84% 48.34%
Operating Profit -$22.35M -$53.28M -$7.999M
YoY Change 179.46% 116.66%
Interest Expense -$70.00K -$5.500M -$5.810M
YoY Change -98.8% -8.33% -4569.23%
% of Operating Profit
Other Income/Expense, Net $0.00 -$5.444M $0.00
YoY Change -23.48%
Pretax Income -$22.43M -$58.72M -$13.81M
YoY Change 62.42% 85.22% 146.61%
Income Tax $10.00K $5.300K $0.00
% Of Pretax Income
Net Earnings -$22.43M -$58.63M -$13.69M
YoY Change 63.83% 88.26% 157.86%
Net Earnings / Revenue -51274.14% -33502.97% -31296.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$415.1K -$1.249M -$348.1K
COMMON SHARES
Basic Shares Outstanding 31.54M
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $177.3M $154.2M $29.85M
YoY Change 493.87% 448.75% 752.77%
Cash & Equivalents $132.5M $132.5M $19.11M
Short-Term Investments $44.74M $21.70M $10.73M
Other Short-Term Assets $48.50K $600.0K $91.66K
YoY Change -47.08% 0.0% -84.72%
Inventory
Prepaid Expenses $588.6K $532.4K
Receivables $0.00 $0.00 $75.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $154.8M $154.8M $28.84M
YoY Change 436.69% 437.5% 339.2%
LONG-TERM ASSETS
Property, Plant & Equipment $3.873M $3.900M $3.513M
YoY Change 10.23% 11.43% -28.24%
Goodwill
YoY Change
Intangibles $1.013M $3.241M
YoY Change -68.72% -32.27%
Long-Term Investments $23.10M $23.10M $1.700M
YoY Change 1258.82% 1258.82% 466.67%
Other Assets $0.00 $0.00 $4.973M
YoY Change -100.0% -1.82%
Total Long-Term Assets $28.02M $28.00M $8.486M
YoY Change 230.15% 229.41% -14.8%
TOTAL ASSETS
Total Short-Term Assets $154.8M $154.8M $28.84M
Total Long-Term Assets $28.02M $28.00M $8.486M
Total Assets $182.8M $182.8M $37.33M
YoY Change 389.74% 390.08% 125.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.579M $2.600M $1.200M
YoY Change 115.02% 116.67% 36.63%
Accrued Expenses $1.399M $4.700M $638.9K
YoY Change 119.05% 213.33% -12.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $300.0K $1.200M
YoY Change -75.0% -75.0% 300.0%
Total Short-Term Liabilities $11.85M $11.80M $8.725M
YoY Change 35.78% 35.63% 63.76%
LONG-TERM LIABILITIES
Long-Term Debt $800.0K $800.0K $1.100M
YoY Change -27.27% -27.27% -47.62%
Other Long-Term Liabilities $255.2K $4.200M $163.4K
YoY Change 56.15% 133.33% -39.28%
Total Long-Term Liabilities $4.984M $5.000M $2.870M
YoY Change 73.69% 72.41% 20.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.85M $11.80M $8.725M
Total Long-Term Liabilities $4.984M $5.000M $2.870M
Total Liabilities $16.83M $16.30M $11.59M
YoY Change 45.16% 66.33% 50.21%
SHAREHOLDERS EQUITY
Retained Earnings -$224.8M -$166.1M
YoY Change 35.29% 23.07%
Common Stock $391.3M $193.6M
YoY Change 102.08% 32.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.5M $166.5M $27.50M
YoY Change
Total Liabilities & Shareholders Equity $182.8M $182.8M $37.33M
YoY Change 389.74% 390.08% 125.86%

Cashflow Statement

Concept 2014 Q3 2014 2013 Q3
OPERATING ACTIVITIES
Net Income -$22.43M -$58.63M -$13.69M
YoY Change 63.83% 88.26% 157.86%
Depreciation, Depletion And Amortization $200.0K $1.346M $400.0K
YoY Change -50.0% -23.17% 0.0%
Cash From Operating Activities -$10.90M -$35.40M -$5.400M
YoY Change 101.85% 86.32% 20.0%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K $1.717M -$100.0K
YoY Change 300.0% 478.47% 0.0%
Acquisitions
YoY Change
Other Investing Activities $5.000M -$34.80M -$6.400M
YoY Change -178.13% 278.26% -3300.0%
Cash From Investing Activities $4.500M -$36.50M -$6.500M
YoY Change -169.23% 284.21% -6600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $172.6M
YoY Change 287.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K 185.3M 2.000M
YoY Change -75.0% 318.28% -63.64%
NET CHANGE
Cash From Operating Activities -10.90M -35.40M -5.400M
Cash From Investing Activities 4.500M -36.50M -6.500M
Cash From Financing Activities 500.0K 185.3M 2.000M
Net Change In Cash -5.900M 113.4M -9.900M
YoY Change -40.4% 617.72% -1000.0%
FREE CASH FLOW
Cash From Operating Activities -$10.90M -$35.40M -$5.400M
Capital Expenditures -$400.0K $1.717M -$100.0K
Free Cash Flow -$10.50M -$37.12M -$5.300M
YoY Change 98.11% 92.35% 20.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3872753
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
588626
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
48502
CY2014Q3 us-gaap Assets Current
AssetsCurrent
154800770
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
1241404
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5443826
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58720112
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31703079
CY2014 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-78874
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-53276286
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-24589276
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6439323
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5894008
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3488864
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
18
CY2014Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21653032
CY2014Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
23088346
CY2013Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1702153
CY2014Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
41414
CY2013Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
30011
CY2014Q3 us-gaap Assets
Assets
182816756
CY2013Q3 us-gaap Assets
Assets
37329631
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2579478
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1199632
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1399486
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
638884
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3268506
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
905771
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
103125
CY2014Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4173943
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4096363
CY2014Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
213991
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
221345
CY2014Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58495
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11847024
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
50000
CY2014Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
758340
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1061113
CY2014Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3970931
CY2013Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
10
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
147026
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32489444
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32489444
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
166540443
CY2014Q3 us-gaap Minority Interest
MinorityInterest
-555188
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166140969
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
27498666
CY2013Q3 us-gaap Minority Interest
MinorityInterest
-1763877
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
971557
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
588343
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8725020
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
255206
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163436
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4984477
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2869822
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-224771159
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2579
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
103125
CY2013Q3 us-gaap Assets Current
AssetsCurrent
28843719
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3513235
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
165985255
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
18300
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
532354
CY2013 us-gaap Operating Expenses
OperatingExpenses
24879542
CY2014 us-gaap Operating Expenses
OperatingExpenses
53451286
CY2014 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12829355
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-21089211
CY2013 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6667669
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25734789
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37329631
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182816756
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54656936
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2014 us-gaap Revenues
Revenues
175000
CY2013 us-gaap Revenues
Revenues
290266
CY2012 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6414921
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54656936
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2375658
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1241404
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3240513
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1421652
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
91660
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1013473
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9900
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
18300
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9900
CY2012 us-gaap Revenues
Revenues
146875
CY2012 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-240154
CY2012 us-gaap Operating Expenses
OperatingExpenses
21236086
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3081186
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1345655
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
5696173
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1536271
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1751412
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1748975
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-76388
CY2013 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-641141
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82092
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-58878
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1021432
CY2014 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
645493
CY2013 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-97910
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6033659
CY2013 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5300389
CY2012 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
386892
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-997975
CY2011Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12564167
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23833
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
124859
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
391164558
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193514766
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2172387
CY2013 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1308047
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24002224
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11129766
CY2014 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-95222
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-58630190
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-31143289
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.25
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.30
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.90
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46933030
CY2014Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23138050
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8705627
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5391463
CY2012 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1642775
CY2012 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
1576107
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1079377
CY2012 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-58091
CY2012 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35966
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7113803
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22110643
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5300
CY2014 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-58725412
CY2013 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-31703079
CY2012 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-22110643
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-354
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-80
CY2012 us-gaap Profit Loss
ProfitLoss
-22110723
CY2013 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-560144
CY2012 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-984795
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-21125928
CY2012 arwr Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
50406
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8808909
CY2013 arwr Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
2054599
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1536271
CY2013 arwr Subscription Receivable
SubscriptionReceivable
16000
CY2013 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1600989
CY2014 arwr Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
10148044
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2730000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5696173
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5956079
CY2014 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1303911
CY2013 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-354
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-80
CY2012 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-58091
CY2012 arwr Provision For Allowance For Bad Debts And Sales Related Allowances
ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances
2497300
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
793887
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
128406
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9390
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-84721
CY2014 arwr Non Cash Gain In Equity Investment
NonCashGainInEquityInvestment
87197
CY2014 arwr Non Cash Impairment Charges
NonCashImpairmentCharges
2172387
CY2013 arwr Non Cash Impairment Charges
NonCashImpairmentCharges
2315721
CY2012 arwr Non Cash Impairment Charges
NonCashImpairmentCharges
1642775
CY2012 us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
-240154
CY2014 arwr Noncontrolling Interest
NoncontrollingInterest
95222
CY2013 arwr Noncontrolling Interest
NoncontrollingInterest
560144
CY2012 arwr Noncontrolling Interest
NoncontrollingInterest
984795
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
65625
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-162855
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
25867
CY2013 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1080
CY2012 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
938179
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15812
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-44713
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
338531
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13287
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1811
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
30600
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1412275
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
321647
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
291876
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3478094
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
27920
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
186369
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
882296
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
94257
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-187910
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-35416373
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19032826
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15340090
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1717362
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
296880
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
479710
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
89505
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
290312
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46365528
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10732571
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11591120
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1419079
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
509009
CY2012 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
-121033
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36481770
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9520867
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
440644
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
225406
CY2013 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
214801
CY2012 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
196606
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
172641671
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
42448826
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10883992
CY2014 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
12878044
CY2013 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
2057178
CY2012 arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
74239
CY2012 arwr Proceeds From Sale Of Stock In Subsidiary
ProceedsFromSaleOfStockInSubsidiary
8000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
185294309
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
44291203
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10769625
CY2013 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-354
CY2012 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-280
CY2014 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
CY2013 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
CY2012 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
CY2014 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2013 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2012 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2013 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-354
CY2012 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-280
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
113396166
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15737156
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4130101
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3377288
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7507389
CY2014 us-gaap Interest Paid
InterestPaid
25635
CY2013 us-gaap Interest Paid
InterestPaid
42044
CY2012 us-gaap Interest Paid
InterestPaid
42269
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6594421
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains bank accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2014 arwr Net Cash Invested In Fixed Income Investments
NetCashInvestedInFixedIncomeInvestments
34800000
CY2014Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2014Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2014Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
334162
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
323376
CY2014Q3 arwr Research Equipment
ResearchEquipment
4614176
CY2013Q3 arwr Research Equipment
ResearchEquipment
3452013
CY2014Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2013Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3045022
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2749409
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4190230
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8062983
CY2014Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
407523
CY2014Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
44333855
CY2014Q3 us-gaap Marketable Securities
MarketableSecurities
44741378
CY2013Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
7500
CY2013Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
41643
CY2013Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
10698271
CY2013Q3 us-gaap Marketable Securities
MarketableSecurities
10732414
CY2014Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
233014
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1026010
CY2012Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2260869
CY2012Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.76
CY2012Q4 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of Common Stock and a warrant to purchase
CY2012Q4 arwr Ratio Of Common Stock To Purchase One Warrant
RatioOfCommonStockToPurchaseOneWarrant
0.5
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1667051
CY2013Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.12
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3500000
CY2013Q1 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of Common Stock and a warrant to purchase
CY2013Q1 arwr Warrant To Purchase Share Of Common Stock
WarrantToPurchaseShareOfCommonStock
0.5
CY2013Q2 arwr Conversion Price Per Share
ConversionPricePerShare
1.83
CY2014 arwr Ownership Percentage In Subsidiary
OwnershipPercentageInSubsidiary
1.00
CY2014Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2014Q3 arwr Threshold Percentage Of Common Stock Ownership Upon Preferred Stock Conversion
ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion
0.0999
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36000000
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3071672
CY2013Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.86
CY2014 arwr Obligation To Pay Royalties
ObligationToPayRoyalties
later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.
CY2011Q4 arwr Present Value Of Contingent Acquisition Consideration
PresentValueOfContingentAcquisitionConsideration
84935
CY2014 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2172387
CY2014 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
55000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
0
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54653
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
236009
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
293964
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
161500
CY2012Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2013Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
944935
CY2012Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1667247
CY2013 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1308047
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123191
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68538
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4784569
CY2012Q3 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of Common Stock and a warrant to purchase
CY2012Q3 arwr Warrant To Purchase Share Of Common Stock
WarrantToPurchaseShareOfCommonStock
0.75
CY2012Q3 arwr Common Stock Exercise Price
CommonStockExercisePrice
3.25
CY2012Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6200000
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1825079
CY2012Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.26
CY2012Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4100000
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.83
CY2013Q4 arwr Conversion Price Per Share
ConversionPricePerShare
5.86
CY2013Q4 arwr Aggregate Price On Issuance Or Sale Of Equity
AggregatePriceOnIssuanceOrSaleOfEquity
64000000
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60000000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6325000
CY2014Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.95
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112600000
CY2011Q4 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2014Q2 us-gaap Revenues
Revenues
43750
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1490589
CY2014 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
554000
CY2013 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
534000
CY2012 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
480000
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
228420
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
228420
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.93
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
228420
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
228420
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
95175
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.03
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
459633
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
36524
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
972331
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
580306
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
596877
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
613664
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
637897
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2888377
CY2014Q3 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
0
CY2014Q3 us-gaap Purchase Obligation
PurchaseObligation
21400000
CY2014Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
19500000
CY2014Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
1900000
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
467322
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1910794
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1509166
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
675
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3419285
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1039000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
152582
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
454863
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3850840
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1684919
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.05
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.05
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.00
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.99
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.94
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
31141826
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15518772
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.018
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.009
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.024
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.023
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.017
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.90
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.00
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.92
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.88
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.32
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5821796
CY2014 arwr Term Of Exchange Rights
TermOfExchangeRights
P7Y
CY2012Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
173621
CY2013 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
0
CY2014Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1313354
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
159015
CY2013 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
0
CY2013 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
-1421652
CY2014 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
0
CY2013Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59321135
CY2014Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3011369
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2013Q3 arwr Deferred Tax Asset Fair Value Adjustments
DeferredTaxAssetFairValueAdjustments
749030
CY2014 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
0
CY2014 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
-2375658
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42268526
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
52133035
CY2014Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62227372
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1269020
CY2014Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
13536745
CY2013Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3985025
CY2014Q3 arwr Deferred Tax Asset Fair Value Adjustments
DeferredTaxAssetFairValueAdjustments
1864364
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-55224802
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-52214090
CY2014Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
-6277587
CY2013Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
-5042010
CY2014Q3 arwr Deferred Tax Liabilities Equity Investments
DeferredTaxLiabilitiesEquityInvestments
-7675
CY2014Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
-475829
CY2013Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
-1521015
CY2014Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
-241479
CY2013Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
-544020
CY2014Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
-7002570
CY2013Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
-7107045
CY2014Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2013Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2014 arwr Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1.00
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
24200000
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
64100000
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
37900000
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
80000000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2014 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
CY2013 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5300
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2014 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
5300
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.076
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.103
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.001
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.011
CY2014 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.035
CY2013 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.058
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.001
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.052
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.374
CY2014 arwr Effective Income Tax Rate Reconciliation Write Off Net Operating Losses
EffectiveIncomeTaxRateReconciliationWriteOffNetOperatingLosses
0.327
CY2013 arwr Effective Income Tax Rate Reconciliation Write Off Net Operating Losses
EffectiveIncomeTaxRateReconciliationWriteOffNetOperatingLosses
0.000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
264193000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
191947000
CY2014Q3 us-gaap Revenues
Revenues
43750
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7009382
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-13982700
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-6177628
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-13805059
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11212498
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12700100
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-11626451
CY2014Q3 us-gaap Profit Loss
ProfitLoss
-22430889
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
162495000
CY2013Q4 us-gaap Revenues
Revenues
43750
CY2014Q1 us-gaap Revenues
Revenues
43750
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-4614159
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6757937
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-6079010
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-13692183
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22354306
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2013Q4 us-gaap Profit Loss
ProfitLoss
-10685372
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-10628312
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-13942521
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-11626919
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-22432438
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2012Q4 us-gaap Revenues
Revenues
159016
CY2013Q1 us-gaap Revenues
Revenues
43750
CY2013Q2 us-gaap Revenues
Revenues
43750
CY2013Q3 us-gaap Revenues
Revenues
43750
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4810021
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5390288
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6389865
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7999102
CY2012Q4 us-gaap Profit Loss
ProfitLoss
-4780727
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-6940019

Files In Submission

Name View Source Status
0001564590-14-005961-index-headers.html Edgar Link pending
0001564590-14-005961-index.html Edgar Link pending
0001564590-14-005961.txt Edgar Link pending
0001564590-14-005961-xbrl.zip Edgar Link pending
arwr-10k_20140930.htm Edgar Link pending
arwr-20140930.xml Edgar Link completed
arwr-20140930.xsd Edgar Link pending
arwr-20140930_cal.xml Edgar Link unprocessable
arwr-20140930_def.xml Edgar Link unprocessable
arwr-20140930_lab.xml Edgar Link unprocessable
arwr-20140930_pre.xml Edgar Link unprocessable
arwr-ex211_2014093012.htm Edgar Link pending
arwr-ex231_201409307.htm Edgar Link pending
arwr-ex311_2014093011.htm Edgar Link pending
arwr-ex312_2014093010.htm Edgar Link pending
arwr-ex321_2014093013.htm Edgar Link pending
arwr-ex322_201409309.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g20141125185812197784.jpg Edgar Link pending
g20141125185812291785.jpg Edgar Link pending
g20141125185812853786.jpg Edgar Link pending
g20141125185813025787.jpg Edgar Link pending
g20141125185813088788.jpg Edgar Link pending
g20141125185813260789.jpg Edgar Link pending
g20141125185814650790.jpg Edgar Link pending
g20141125185814806791.jpg Edgar Link pending
g20141125185815494792.jpg Edgar Link pending
g20141125185815556793.jpg Edgar Link pending
g20141125185815619794.jpg Edgar Link pending
g20141125185815900795.jpg Edgar Link pending
g20141125185816056796.jpg Edgar Link pending
g20141125185816416797.jpg Edgar Link pending
g20141125185816697798.jpg Edgar Link pending
g20141125185816822799.jpg Edgar Link pending
g20141125185817010800.jpg Edgar Link pending
g20141125185823619801.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending